Table 1.
PCa |
|||
---|---|---|---|
Yes | No | ||
No. (%) | 706 (12) | 5284 (88) | |
|
|||
Baseline characteristic | p value | ||
Age, no. (%) | |||
65–69 yr | 131 (18.6) | 1638 (31.0) | <0.0001 |
70–79 yr | 377 (53.4) | 2777 (52.6) | |
≥80 yr | 198 (28.0) | 869 (16.5) | |
Caucasian race, no. (%) | 625 (88.5) | 4733 (89.6) | 0.40 |
BMI, kg/m2, mean (SD) | 27.4 (3.8) | 27.4 (3.8) | 0.76 |
Alcohol consumption, drinks per week, median (IQR) | 1.0 (0.0–7.0) | 1.0 (0.0–7.0) | 0.69 |
No | 280 (39.7) | 1967 (37.2) | 0.03 |
Past | 413 (58.5) | 3124 (59.1) | |
Current | 13 (1.8) | 192 (3.6) | |
Self-reported health fair or poor, no. (%) | 125 (17.7) | 732 (13.9) | 0.006 |
Previous BPH diagnosis, no. (%) | 389 (55.1) | 2539 (48.1) | 0.0004 |
Medical history, no. (%) | |||
Any heart disease | 159 (22.5) | 1269 (24.0) | 0.38 |
Self-reported diabetes | 67 (9.5) | 586 (11.1) | 0.20 |
Self-reported hypertension | 304 (43.1) | 2276 (43.1) | 0.99 |
Self-reported cancer, not PCa | 216 (30.6) | 1036 (19.6) | <0.0001 |
Years since PCa diagnosis, mean (SD) | 6.3 (4.8) | – | – |
PCa major treatment, no. (%) | |||
Surgery | 362 (51.3) | – | – |
Radiation therapy | 204 (29.0) | – | – |
Hormones | 68 (9.6) | – | – |
Observation | 42 (6.0) | – | – |
Other treatment | 30 (4.3) | – | – |
PCa = prostate cancer; BMI = body mass index; SD = standard deviation; IQR = interquartile range; BPH = benign prostatic hyperplasia.